Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 6/2020

Ausgabe 6/2020

Inhaltsverzeichnis ( 21 Artikel )

28.04.2020 | COVID-19 | Editorial | Ausgabe 6/2020 Zur Zeit gratis

Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19

Haidong Dong

22.04.2020 | Review | Ausgabe 6/2020

Advances and perspectives of dendritic cell-based active immunotherapies in follicular lymphoma

Maria Christina Cox, Caterina Lapenta, Stefano M. Santini

19.02.2020 | Original Article | Ausgabe 6/2020

Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors

Qing Wu, Junjin Liu, Yanhong Zhang, Sumei Wu, Xianhe Xie

11.03.2020 | Correction | Ausgabe 6/2020

Correction to: Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors

Qing Wu, Junjin Liu, Yanhong Zhang, Sumei Wu, Xianhe Xie

20.02.2020 | Original Article | Ausgabe 6/2020

Development and characterization of a novel anti-OX40 antibody for potent immune activation

Zhihui Kuang, Hua Jing, Zhihai Wu, Jie Wang, Yiming Li, Haiqing Ni, Pan Zhang, Weiwei Wu, Min Wu, Shuaixiang Zhou, Xuan Qiu, Dongdong Wu, Bianka Prinz, Hemanta Baruah, Bingliang Chen, Michael Yu, Junjian Liu

20.02.2020 | Original Article | Ausgabe 6/2020

miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy

Meng Zhang, Yanmei Shi, Yujuan Zhang, Yifan Wang, Faizah Alotaibi, Li Qiu, Hongmei Wang, Shanshan Peng, Yanling Liu, Qing Li, Dian Gao, Zhigang Wang, Keng Yuan, Fang-fang Dou, James Koropatnick, Jianping Xiong, Weiping Min

20.02.2020 | Original Article | Ausgabe 6/2020

CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies

Ashanty M. Melo, Melissa J. Conroy, Emma K. Foley, Éilis Dockry, Eamon P. Breen, John V. Reynolds, Joanne Lysaght, Derek G. Doherty

20.02.2020 | Original Article | Ausgabe 6/2020

Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection

Ilya Tsimafeyeu, Rustem Gafanov, Svetlana Protsenko, Anna Semenova, Ani Oganesyan, Nurzhan Nurgaliyev, Sergei Krasny, Anastasia Bondarenko, Sufia Safina, Kristina Zakurdaeva

21.02.2020 | Original Article | Ausgabe 6/2020

Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer

Mizuho Ohara, Kenzo Ohara, Takumi Kumai, Takayuki Ohkuri, Toshihiro Nagato, Yui Hirata-Nozaki, Akemi Kosaka, Marino Nagata, Ryusuke Hayashi, Shohei Harabuchi, Yuki Yajima, Kensuke Oikawa, Yasuaki Harabuchi, Yasuo Sumi, Hiroyuki Furukawa, Hiroya Kobayashi

22.02.2020 | Original Article | Ausgabe 6/2020

Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model

Jose-Ignacio Rodriguez-Barbosa, Miyuki Azuma, Gennadiy Zelinskyy, Jose-Antonio Perez-Simon, Maria-Luisa del Rio

22.02.2020 | Original Article | Ausgabe 6/2020 Open Access

Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro

Shannon Burke, Amy Shergold, Matthew J. Elder, Justine Whitworth, Xing Cheng, Hong Jin, Robert W. Wilkinson, James Harper, Danielle K. Carroll

25.02.2020 | Original Article | Ausgabe 6/2020 Open Access

Prostaglandin E2 in a TLR3- and 7/8-agonist-based DC maturation cocktail generates mature, cytokine-producing, migratory DCs but impairs antigen cross-presentation to CD8+ T cells

Philipp Gierlich, Veronika Lex, Antje Technau, Anne Keupp, Lorenz Morper, Amelie Glunz, Hanno Sennholz, Johannes Rachor, Sascha Sauer, Ana Marcu, Götz Ulrich Grigoleit, Matthias Wölfl, Paul G. Schlegel, Matthias Eyrich

25.02.2020 | Original Article | Ausgabe 6/2020 Open Access

Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival

Karl-Frederick Karstens, Jan Kempski, Anastasios D. Giannou, Penelope Pelczar, Babett Steglich, Stefan Steurer, Eric Freiwald, Anna Woestemeier, Leonie Konczalla, Michael Tachezy, Matthias Reeh, Maximilian Bockhorn, Daniel Perez, Oliver Mann, Ansgar W. Lohse, Thomas Roesch, Jakob R. Izbicki, Nicola Gagliani, Samuel Huber

25.02.2020 | Original Article | Ausgabe 6/2020

Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications

Yu-Jie Zhou, Gui-Qi Zhu, Xiao-Fan Lu, Kenneth I. Zheng, Qi-Wen Wang, Jin-Nan Chen, Qing-Wei Zhang, Fang-Rong Yan, Xiao-Bo Li

26.02.2020 | Original Article | Ausgabe 6/2020

Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma

Asif A. Dar, Rushikesh S. Patil, Trupti N. Pradhan, Devendra A. Chaukar, Anil K. D’Cruz, Shubhada V. Chiplunkar

26.02.2020 | Original Article | Ausgabe 6/2020

Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma

Lata Singh, Mithalesh Kumar Singh, Moshahid Alam Rizvi, Sameer Bakhshi, Rachna Meel, Neiwete Lomi, Seema Sen, Seema Kashyap

28.02.2020 | Original Article | Ausgabe 6/2020 Open Access

Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy

Malgorzata Wachowska, Joanna Stachura, Katarzyna Tonecka, Klaudyna Fidyt, Agata Braniewska, Zuzanna Sas, Iwona Kotula, Tomasz Piotr Rygiel, Louis Boon, Jakub Golab, Angelika Muchowicz

29.02.2020 | Original Article | Ausgabe 6/2020 Open Access

Neutrophils are mediators of metastatic prostate cancer progression in bone

Diane L. Costanzo-Garvey, Tyler Keeley, Adam J. Case, Gabrielle F. Watson, Massar Alsamraae, Yangsheng Yu, Kaihong Su, Cortney E. Heim, Tammy Kielian, Colm Morrissey, Jeremy S. Frieling, Leah M. Cook

11.02.2020 | Clinical Trial Report | Ausgabe 6/2020

Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study

Eiji Kiyohara, Atsushi Tanemura, Megumi Nishioka, Mizuho Yamada, Aya Tanaka, Akinori Yokomi, Atsuhiro Saito, Kazuma Sakura, Toshihiro Nakajima, Akira Myoui, Toshiharu Sakurai, Yutaka Kawakami, Yasufumi Kaneda, Ichiro Katayama

06.02.2020 | Meeting Report | Ausgabe 6/2020

Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy

Matteo Bellone, Arianna Brevi, Stefania Bruzzì, Michela Consonni, Francesca De Santis, Giulia Di Lullo, Maria Teresa Majorini, Anna Pastò, Alberto Amadori, Marco Bregni, Massimo Di Nicola, Luana Calabrò, Pier Francesco Ferrucci, Enrico Proietti, Mario Paolo Colombo, Vincenzo Russo

09.03.2020 | Letter to the Editors | Ausgabe 6/2020

ESTIMATE algorithm is not appropriate for inferring tumor purity and stromal and immune cell admixture in hematopoietic or stromal tumors

Qiang Liu, Yi Fang, Jing Wang

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise